ADAMTS19 was hypermethylated in 48 % of adenomas, 35 % of adenocarcinomas, and 31 % of metastases but never in the 322 normal tissues corresponding to the tumoral samples. This evidence concerns the gene ADAMTS19 and adenocarcinoma.